/OZYMF
OZYMF Stock - Strategic Partners A/S
Healthcare|BiotechnologyOTC
$90.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $99.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OZYMF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$89.10 – $90.90
TARGET (TP)$103.50
STOP LOSS$82.80
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.10
52W High$90.00
52W Low$0.09
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $36.19M | N/A |
| Gross Profit | N/A | N/A | $-782,000 | $18.08M | $-5,199,000 |
| Gross Margin | N/A | N/A | N/A | 50.0% | N/A |
| Operating Income | $-201 | $-27,041,000 | $-41,241,000 | $-83,472,000 | $-608,534,000 |
| Net Income | $-298 | $-26,048,000 | $-110,594,000 | $-626,539,000 | $-633,246,000 |
| Net Margin | N/A | N/A | N/A | -1731.1% | N/A |
| EPS | $0.00 | $-0.00 | $-3.14 | $-17.94 | $-22.32 |
Company Overview
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
OZYMFBeat Rate
80%
Last 5 quarters
Avg Surprise
+49.4%
EPS vs Estimate
Beats / Misses
4/1
Last 12 quarters
Latest EPS
$-4.42
Q4 2025
EPS Surprise History
Q3 21
-151.7%
$-13.29vs$-5.28
Q2 22
+99.5%
$-4.66vs$-855.88
Q3 22
+99.7%
$-2.35vs$-692.26
Q4 22
+99.8%
$-1.04vs$-593.91
Q2 23
No data
Q2 24
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 21, 2025 | — | $-4.42 | — | — |
Q2 2025 | May 22, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 18, 2024 | — | — | — | — |
Q2 2024 | May 14, 2024 | — | $-0.38 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.36 | — | — |
Q4 2022 | Dec 30, 2022 | $-593.91 | $-1.04 | +99.8% | ✓ BEAT |
Q3 2022 | Sep 26, 2022 | $-692.26 | $-2.35 | +99.7% | ✓ BEAT |
Q2 2022 | Jun 7, 2022 | $-855.88 | $-4.66 | +99.5% | ✓ BEAT |
Q3 2021 | Aug 31, 2021 | $-5.28 | $-13.29 | -151.7% | ✗ MISS |
Q1 2021 | Mar 2, 2021 | $-2540.05 | $-12.44 | +99.5% | ✓ BEAT |
Q3 2020 | Aug 26, 2020 | — | $-9.88 | — | — |
Q1 2020 | Feb 28, 2020 | — | $-8.69 | — | — |
Q3 2019 | Aug 28, 2019 | — | $-8.21 | — | — |
Q1 2019 | Mar 1, 2019 | — | $-6.08 | — | — |
Q3 2018 | Aug 22, 2018 | — | $-5.41 | — | — |
Q1 2018 | Mar 15, 2018 | — | $-5.31 | — | — |
Q4 2017 | Nov 16, 2017 | — | $-5.09 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-2.94 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-2.71 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-2.33 | — | — |
Latest News
Loading news...
Frequently Asked Questions about OZYMF
What is OZYMF's current stock price?
Strategic Partners A/S (OZYMF) is currently trading at $90.00 per share. The stock has moved +0.00% today.
What is the analyst price target for OZYMF?
No analyst price targets are currently available for this stock.
What sector is Strategic Partners A/S in?
Strategic Partners A/S operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is OZYMF's market cap?
Strategic Partners A/S has a market capitalization of $0.00 billion, making it a small-cap company.
Does OZYMF pay dividends?
No, Strategic Partners A/S does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorEVLO
Evelo Biosciences, Inc.
$0.00
Mkt Cap: $0.0B
HLUN
HEALTHeUNIVERSE, Inc.
$0.00
Mkt Cap: $0.0B
NNLX
NanoLogix, Inc.
$0.00
Mkt Cap: $0.0B
PXMD
PaxMedica, Inc. Common Stock
$0.00
Mkt Cap: $0.0B
QBIO
Q BioMed Inc.
$0.00
Mkt Cap: $0.0B
SDCCQ
SmileDirectClub, Inc.
$0.00
Mkt Cap: $0.0B
TRVN
Trevena, Inc.
$0.01
Mkt Cap: $0.0B
USMJ
North American Cannabis Holdings, Inc.
$0.00
Mkt Cap: $0.0B
VAXX
Vaxxinity, Inc.
$0.00
Mkt Cap: $0.0B
XSNX
NovAccess Global Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to OZYMF for comparison